ScholarGate
Βοηθός

Σύγκριση μεθόδων

Εξετάστε τις επιλεγμένες μεθόδους δίπλα-δίπλα· οι γραμμές που διαφέρουν επισημαίνονται.

Διαγνωστικά Κριτήρια Rome IV για το Σύνδρομο Ευερέθιστου Εντέρου×Ερωτηματολόγιο Φλεγμονωδών Νοσημάτων του Εντέρου (Σύντομη Μορφή)×
ΠεδίοΓαστρεντερολογίαΓαστρεντερολογία
ΟικογένειαProcess / pipelineProcess / pipeline
Έτος προέλευσης20162004
ΔημιουργόςRome Foundation (multinational expert consensus)Guyonnet, D., Chassany, O., Ducroc, R., et al.
ΤύποςDiagnostic CriteriaSelf-report
Θεμελιώδης πηγήMearin, F., Lacy, B. E., Chang, L., et al. (2016). Bowel disorders. Gastroenterology. Published online June 2016 by the Rome Foundation. link ↗Guyonnet, D., Chassany, O., Ducroc, R., Picard, C., Mouret, M., D'Haens, G., & Svartz, H. (2004). Effect of fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in France: A multicentre, randomized, double-blind, controlled trial. Alimentary Pharmacology & Therapeutics, 20(4), 459–465. link ↗
Εναλλακτικές ονομασίεςRome IV IBS, Rome CriteriaIBDQ-32, Short IBDQ
Συναφείς44
ΣύνοψηThe Rome IV criteria are the internationally accepted diagnostic standard for irritable bowel syndrome (IBS), published in 2016 by the Rome Foundation. These criteria define IBS as recurrent abdominal pain (≥1 day per week for ≥3 months) associated with altered bowel habits, without structural or biochemical abnormalities. IBS is subtyped into four patterns—IBS-constipation predominant (IBS-C), IBS-diarrhea predominant (IBS-D), IBS-mixed (IBS-M), and IBS-unclassified (IBS-U)—based on stool consistency patterns.The Short Inflammatory Bowel Disease Questionnaire (IBDQ-32) is a validated patient-reported outcome measure designed to assess the impact of inflammatory bowel disease (IBD)—both ulcerative colitis and Crohn's disease—on health-related quality of life. Derived from the original 32-item IBDQ, this instrument comprises four domains: Bowel Symptoms, Systemic Symptoms, Social Function, and Emotional Function. The IBDQ-32 is responsive to treatment and is increasingly used in IBD clinical trials and practice.
ScholarGateΣύνολο δεδομένων
  1. v1
  2. 1 Πηγές
  3. PUBLISHED
  1. v1
  2. 1 Πηγές
  3. PUBLISHED

Μετάβαση στην αναζήτηση Λήψη διαφανειών

ScholarGateΣύγκριση μεθόδων: Rome IV Irritable Bowel Syndrome Criteria · Short Inflammatory Bowel Disease Questionnaire. Ανακτήθηκε στις 2026-06-20 από https://scholargate.app/el/compare